GB9925069D0 - Oral dosage form - Google Patents

Oral dosage form

Info

Publication number
GB9925069D0
GB9925069D0 GBGB9925069.8A GB9925069A GB9925069D0 GB 9925069 D0 GB9925069 D0 GB 9925069D0 GB 9925069 A GB9925069 A GB 9925069A GB 9925069 D0 GB9925069 D0 GB 9925069D0
Authority
GB
United Kingdom
Prior art keywords
dosage form
oral dosage
oral
dosage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB9925069.8A
Other versions
GB2355406A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alkaloid AD Skopje
Original Assignee
Alkaloid AD Skopje
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alkaloid AD Skopje filed Critical Alkaloid AD Skopje
Priority to GB9925069A priority Critical patent/GB2355406A/en
Publication of GB9925069D0 publication Critical patent/GB9925069D0/en
Priority to PCT/GB2000/003429 priority patent/WO2001030321A1/en
Priority to EP00958814A priority patent/EP1221944A1/en
Priority to PL00354872A priority patent/PL354872A1/en
Priority to RU2002110329/15A priority patent/RU2002110329A/en
Priority to AU70232/00A priority patent/AU7023200A/en
Priority to CA002388123A priority patent/CA2388123A1/en
Priority to US09/658,205 priority patent/US6572891B1/en
Priority to ARP000105062A priority patent/AR025791A1/en
Publication of GB2355406A publication Critical patent/GB2355406A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
GB9925069A 1999-10-23 1999-10-23 A sub-lingual dosage form comprising a morphine salt Withdrawn GB2355406A (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
GB9925069A GB2355406A (en) 1999-10-23 1999-10-23 A sub-lingual dosage form comprising a morphine salt
CA002388123A CA2388123A1 (en) 1999-10-23 2000-09-07 Oral dosage form comprising a salt of morphine or a morphine derivative
RU2002110329/15A RU2002110329A (en) 1999-10-23 2000-09-07 ORAL DOSAGE FORM CONTAINING MORPHINE SALT OR MORPHINE DERIVATIVE
EP00958814A EP1221944A1 (en) 1999-10-23 2000-09-07 Oral dosage form comprising a salt of morphine or a morphine derivative
PL00354872A PL354872A1 (en) 1999-10-23 2000-09-07 Oral dosage form comprising a salt of morphine or a morphine derivative
PCT/GB2000/003429 WO2001030321A1 (en) 1999-10-23 2000-09-07 Oral dosage form comprising a salt of morphine or a morphine derivative
AU70232/00A AU7023200A (en) 1999-10-23 2000-09-07 Oral dosage form comprising a salt of morphine or a morphine derivative
US09/658,205 US6572891B1 (en) 1999-10-23 2000-09-08 Sublingual oral dosage form
ARP000105062A AR025791A1 (en) 1999-10-23 2000-09-27 ORAL DOSAGE FORM

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9925069A GB2355406A (en) 1999-10-23 1999-10-23 A sub-lingual dosage form comprising a morphine salt

Publications (2)

Publication Number Publication Date
GB9925069D0 true GB9925069D0 (en) 1999-12-22
GB2355406A GB2355406A (en) 2001-04-25

Family

ID=10863232

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9925069A Withdrawn GB2355406A (en) 1999-10-23 1999-10-23 A sub-lingual dosage form comprising a morphine salt

Country Status (1)

Country Link
GB (1) GB2355406A (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL294106A (en) * 1962-06-14
US5580876A (en) * 1992-09-21 1996-12-03 Albert Einstein College Of Medicine Of Yeshiva University, A Division Of Yeshiva University Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists
US5411745A (en) * 1994-05-25 1995-05-02 Euro-Celtique, S.A. Powder-layered morphine sulfate formulations
WO1999040898A2 (en) * 1998-02-12 1999-08-19 Centrapharm Inc. Sublingual drug formulations having combined rapid onset of action and long lasting therapeutic effect

Also Published As

Publication number Publication date
GB2355406A (en) 2001-04-25

Similar Documents

Publication Publication Date Title
HUP0203204A3 (en) Oral dosage forms
ZA200202480B (en) Oral dosage forms.
EG23943A (en) Flash-melt oral dosage formulation
HK1090840A1 (en) Extended release oral dosage composition
IL149224A0 (en) Hydrogen-driven drug dosage form
EG23759A (en) Stable extended release oral dosage composition
AU6089200A (en) Rapid immediate release oral dosage form
AU1998200A (en) Multiparticulate oral dosage forms
HK1044476A1 (en) Medicinal compositions
GB2351272B (en) Oral medicine dispenser
EP1166786A4 (en) Medicinal compositions
IL138192A0 (en) Controlled release oral dosage forms
GB9923045D0 (en) New oral formulations
IL146152A0 (en) Prucalopride oral solution
HUP0201914A2 (en) Oral care composition
EP1210935A4 (en) Medicinal compositions for oral use
HK1047232A1 (en) Oral dosage forms
GB9925069D0 (en) Oral dosage form
IL132006A0 (en) Stable pharmaceuticl oral dosage forms
GB0014497D0 (en) Oral dosage form
IL128582A0 (en) Pharmaceutical dosage form
SI1245232T1 (en) Oral solid preparation
PL341178A1 (en) Oral pharmaceutical dosage forms
GB9906607D0 (en) Oral composition
IL123341A0 (en) Pharmaceutical dosage form

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)